Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 463-707, South Korea
NCT Number: NCT02151305
We investigated the hemostatic differences according to the main anesthetic agents by analyzing rotational thromboelastometry (ROTEM) under the hypothesis that propofol-based anesthesia would impair postoperative coagulability more than the sevoflurane-based anesthesia.
Looking for future studies?
Notify Me20 year–80 year
All sexes
Interventional
Not applicable
Seongnam-si, Gyeonggi-do, 463-707, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 10 minutes before the induction of anesthesia, 1 h after finishing anesthesia
Time frame: 10 minutes before the induction of anesthesia, 1 h after finishing anesthesia
Time frame: 10 minutes before the induction of anesthesia, 1 h after finishing anesthesia
Time frame: 10 minutes before the induction of anesthesia, 1 h after finishing anesthesia
Time frame: 10 minutes before the induction of anesthesia
Time frame: 10 minutes before the induction of anesthesia
Time frame: 10 minutes before the induction of anesthesia
Time frame: 10 minutes before the induction of anesthesia
Time frame: 10 minutes before the induction of anesthesia
Time frame: 10 minutes before the induction of anesthesia
Seoul National University Bundang Hospital
Other
The Influence of Propofol and Sevoflurane on Hemostasis During Ophthalmic Surgery: Rotational Thromboelastographic Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02138019
Cataract, Conjunctival Diseases
Taipei, Taiwan
View Trial DetailsNCT07228091
Cataract, Epiretinal Membrane
Manchester, United Kingdom
View Trial DetailsNCT06229379
Cardiovascular Diseases, Cataract
Guangzhou, Guangdong, China
View Trial DetailsNCT07634913
Artifical Intelligence, Bacterial Infections
Guangzhou, Guangdong, China
View Trial Details